Amphioxus Cell Technologies Company Profile

08:07 EDT 20th March 2018 | BioPortfolio

Amphioxus Cell Technologies is a biotechnology company based in Houston, Texas.The Company was founded by James Kelly and Norman Sussman to develop human liver based ADME/Tox tools. Our ACTIVTox® product achieves this goal by combining a highly developed human liver cell line with meaningful, high throughput assays.


11222 Richmond Ave., Suite 180
United States of America


Phone: 281.679.7900
Fax: 281.679.7910

News Articles [1465 Associated News Articles listed on BioPortfolio]

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims ...

Opinion: How to Define Cell Type

Advances in single-cell technologies have revealed vast differences between cells once thought to be in the same category, calling into question how we define cell type in the first place.

Karolinska University Hospital And GE Healthcare Collaborate To Advance Technologies For Cell Therapy

Karolinska University Hospital Sweden and GE Healthcare Life Sciences recently announced a joint research collaboration to drive advances in technologies and workflows for use in the rapidly emerging ...

Corning and CytoSMART Announce Agreement for Cell Counting Device

Corning to become exclusive supplier of CytoSMART’s new Cell Counter. Corning Incorporated (NYSE: GLW) and CytoSMART Technologies BV has announced an agreement that will simplify mammalian cell ...

Sartorius inks deal for Quad's T cell activation tech

Quad Technologies has teamed with Sartorius Stedim Biotech to expand the reach of its T-cell activation reagent for cell and gene therapy production.

Artificial Cell Technologies CFO accused of stealing nearly $1m in company funds

A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company through a range of means, it has emerged. 48-year-old Thomas Malone, Chief...

Making an HIV cure: AGT completes process development for T-cell therapy

American Gene Technologies International (AGT) says its HIV candidate is âthe most complex cell therapy the industry has delivered to date.â

PubMed Articles [3164 Associated PubMed Articles listed on BioPortfolio]

A brief review of single-cell transcriptomic technologies.

In recent years, there has been an effort to develop new technologies for measuring gene expression and sequence information from thousands of individual cells. Large data sets that were obtained usin...

Genome-wide gene expression analysis of amphioxus (Branchiostoma belcheri) following lipopolysaccharide challenge using strand-specific RNA-seq.

Amphioxus is the closest living proxy for exploring the evolutionary origin of the immune system in vertebrates. To understand the immune responses of amphioxus to lipopolysaccharide (LPS), five ribos...

T cell clonality assessment: past, present and future.

T cell clonality testing has important clinical and research value, providing a specific and reproducible assessment of clonal diversity in T cell proliferations. Here we review the conceptual foundat...

The impact of single-cell RNA sequencing on understanding the functional organization of the immune system.

Application of single-cell genomics technologies has revolutionized our approach to study the immune system. Unravelling the functional diversity of immune cells and their coordinated response is key ...

Exploring gene expression changes in the amphioxus gill after poly(I:C) challenge using digital expression profiling.

Amphioxus, a cephalochordate, is a key model animal for studying the evolution of vertebrate immunity. Recently, studies have revealed that microRNA (miRNA) expression profiles change significantly in...

Clinical Trials [6051 Associated Clinical Trials listed on BioPortfolio]

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Companies [2192 Associated Companies listed on BioPortfolio]

Amphioxus Cell Technologies

Amphioxus Cell Technologies is a biotechnology company based in Houston, Texas.The Company was founded by James Kelly and Norman Sussman to develop human liver based ADME/Tox tools. Our ACTIVTox® pro...

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

Guava Technologies, Inc

Guava Technologies is a private biotechnology and medical device company that designs and manufactures easy-to-use, on-demand, benchtop cell analysis systems. The company has ISO13485 certificati...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

AVIVA Biosciences Corporation

AVIVA Biosciences CorpBased in San Diego, CA., AVIVA Biosciences Corporation develops enabling drug discovery and development technologies by combining biochips with cell biology. Key application area...

More Information about "Amphioxus Cell Technologies" on BioPortfolio

We have published hundreds of Amphioxus Cell Technologies news stories on BioPortfolio along with dozens of Amphioxus Cell Technologies Clinical Trials and PubMed Articles about Amphioxus Cell Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amphioxus Cell Technologies Companies in our database. You can also find out about relevant Amphioxus Cell Technologies Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Corporate Database Quicklinks

Searches Linking to this Company Record